2014-10-24T07:01:11-07:00 2013-12-31 Bencivenga Ward & Company CPAs PC 420 Columbus Avenue Suite 304 Valhalla NY 105951382 990 2013-01-01 201082179 ALZHEIMERs DRUG DISCOVERY FOUNDATION ALZH 2129018000 57 WEST 57TH ST NEW YORK NY 10019 HOWARD FILLIT MD Executive Director 2014-10-24 true Leonard J Bencivenga CPA P00116788 9147695005 2013 2015-11-30 17:44:51Z HOWARD FILLIT MD 57 WEST 57TH ST NEW YORK NY 10019 9834709 false false X www.AlzDiscovery.org X 2004 DE ACCELERATE THE DISCOVERY AND DEVELOPMENT OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING 15 14 0 0 9676164 9342340 354442 274603 6352 4007 -385581 -330043 9651377 9290907 7462473 7137090 0 97855 220057 0 0 286448 350502 7846776 7707649 1804601 1583258 12592295 14685410 7669159 8179016 4923136 6506394 ACCELERATE THE DISCOVERY AND DEVELOPMENT OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING false false 7707649 7137090 EXEMPT PURPOSE ACHIEVEMENT IS TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING THROUGH THE GRANTING OF FUNDS TO ORGANIZATIONS AND THE SPONSORSHIP OF CONFERENCES THAT BRING TOGETHER ACADEMIC AND BIO TECHNOLOGY SCIENTISTS CONDUCTING DRUG DISCOVERY RESEARCH IN THE FIELD OF ALZHEIMER'S DISEASE, RELATED DEMENTIAS AND COGNITIVE AGING. 7707649 true true false false false false false false false false false false false false true true false true false false true true false false true false false true false true false false false false false false false false false false false true false false false false true false false false false true 17 0 false 0 false false false false false false false true true false 0 false false false false false false false false false false X 15 14 true false false false true true true true true false false true true true true true true false false false X MR ETHAN HUTCHINSON 2129018000 420 COLUMBUS AVENUE VALHALLA NY 10595 X LEONARD A LAUDER Co-Chair / Gov 1.00 0.00 X X 0 0 0 RONALD S LAUDER Co-Chair / Gov 1.00 0.00 X X 0 0 0 HOWARD FILLIT MD EXEC DIR/GOV 0.00 40.00 X X 0 429533 259004 NANCY LYNN UNTIL 813 EX. DIR/COO/GOV 0.00 40.00 X X 0 285983 100094 NANCY CORZINE President/Gov 1.00 0.00 X X 0 0 0 ROBERT A BELFER Governor 1.00 0.00 X 0 0 0 RANDAL SANDLER Governor 1.00 0.00 X 0 0 0 SALLY SUSMAN Governor 1.00 0.00 X 0 0 0 BONNIE PFEIFER EVANS Governor 1.00 0.00 X 0 0 0 LADY LYNN DE ROTHSCHILD Governor 1.00 0.00 X 0 0 0 ALICE SHURE Governor 1.00 0.00 X 0 0 0 MELVIN R GOODES Governor 1.00 0.00 X 0 0 0 PETER J SOLOMON Governor 1.00 0.00 X 0 0 0 PAULA ZAHN GOVERNOR 1.00 0.00 X 0 0 0 NANCY GOODES GOVERNOR 1.00 0.00 X 0 0 0 THOMAS F MCWILLIAMS GOVERNOR 1.00 0.00 X 0 0 0 JOAN KRUPSKAS Treas. To 2/13 1.00 0.00 X 0 0 0 LISA SOMAR ASST TREAS/SEC 1.00 0.00 X 0 0 0 KEVIN DIETERICH Treasurer 1.00 0.00 X 0 0 0 NANCY SANFORD PHILANTHROPY 0.00 40.00 X 0 174337 61018 889853 420116 0 false true false 0 3199428 6142912 80567 9342340 CONFERENCE REG FEES 249603 249603 GRANT RETURN 25000 25000 274603 4007 4007 0 0 0 0 213759 3199428 543802 -330043 -330043 0 0 0 9290907 278610 -330043 6237090 6237090 0 900000 900000 0 0 0 163005 163005 0 0 57052 57052 0 0 0 0 0 0 0 0 1003 1003 11134 11134 0 33365 33365 0 0 276215 276215 0 0 0 0 HONORARIUM 20000 20000 Printing and Publications 8785 8785 0 7707649 7707649 0 0 0 2335165 2640464 2125129 3275097 0 0 0 0 0 16224 10846 0 8115777 8705188 0 0 0 53815 12592295 14685410 41916 36250 7485431 8085501 132049 30765 9763 26500 7669159 8179016 X 4920240 6478494 2896 27900 4923136 6506394 12592295 14685410 1583258 X false true X false false X 2398116 4928614 7946390 9676164 9342340 34291624 0 0 2398116 4928614 7946390 9676164 9342340 34291624 8382315 25909309 3991 2978 6320 6352 4007 23648 0 96406 50184 240733 354442 274603 1016368 35331640 0.73330 0.68870 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED ALZHEIMERS DRUG FD OF CANADA 26500 26500 X Part X : FIN48 Footnote GAAP REQUIRES THE FOUNDATION'S MANAGEMENT TO EVALUATE TAX POSTIONS TAKEN BY THE FOUNDATION AND RECOGNIZE A TAX LIABILITY (OR ASSET) IF THE FOUNDATION HAS TAKEN AN UNCERTAIN POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY THE INTERNAL REVENUE SERVICE. DUE TO THE FOUNDATION'S GENERAL NOT-FOR-PROFIT STATUS, MANAGEMENT BELIEVES THERE ARE NO TAX POSITIONS THAT WOULD HAVE A MATERIAL IMPACT ON THE FOUNDATION'S FINANCIAL STATEMENTS. THE FOUNDATION IS SUBJECT TO ROUTINE AUDITS BY TAXING JURISDICTIONS; HOWEVER, THER ARE CURRENTLY NO AUDITS FOR ANY TAX PERIODS IN PROGRESS. PART X1 LINE 2B AND X111 LINE 2ADURING THE FOUNDATION'S 2013 TAX YEAR, THE INSTITUTE FOR THE STUDY OF AGING, A RELATED TAX-EXEMPT PRIVATE FOUNDATION, PROVIDED THE FOUNDATION WITHOUT CHARGE AS AN IN-KIND CONTRIBUTION SERVICES HAVING A VALUE OF $3,045,271. THESE SERVICES INCLUDED SHARED PERSONNEL AND OFFICE SPACE AND ARE FURTHER DETAILED IN PART V OF SCHEDULE R. true 0 0 RESEARCH RELATED TO 0 EUROPE 0 0 GRANTS TO RECIPIENTS ALZHEIMERS DISEASE 325000 0 0 RESEARCH RELATED TO 0 EUROPE 0 0 GRANTS TO RECIPIENTS ALZHEIMERS DISEASE 310000 0 0 RESEARCH RELATED TO 0 EUROPE 0 0 GRANTS TO RECIPIENTS ALZHEIMERS DISEASE 125000 0 0 RESEARCH RELATED TO 0 EAST ASIA & PACIFIC 0 0 GRANTS TO RECEIPIENTS ALZHEIMERS DISEASE 140000 900000 900000 E ASIA PACIFIC RESEARCH AD 140000 ELECTRONIC EUROPE RESEARCH AD 125000 ELECTRONIC EUROPE RESEARCH AD 310000 ELECTRONIC EUROPE RESEARCH AD 325000 ELECTRONIC 2 2 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US GRANT RECIPIENTS ARE SELECTED THROUGH A RIGOROUS PEER-REVIEW PROCESS AS WELL AS AN INTERNAL REVIEW AND BOARD APPROVAL PROCESS. GRANTS TO BOTH U.S. AND INTERNATIONAL INSTITUTIONS ARE CLOSELY MONITORED. GRANTEES MUST SUBMIT MIDYEAR AND END-OF-GRANT PROGRESS AND FINANCIAL REPORTS. SUBSEQUENT PAYMENTS TO GRANT RECIPIENTS ARE CONTINGENT UPON THE RECEIPT AND SATISFACTORY REVIEW OF THESE REPORTS. PROGRESS OF GRANT RECIPIENTS IS COMMUNICATED TO THE BOARD OF GOVENORS PERIODICALLY. false NY IL GA DINNER GALA 1663160 1591660 71500 106182 96012 FALL SCIENCE 864419 824419 40000 54731 69176 4 885608 783349 102259 14189 81995 121517 3413187 3199428 213759 68920 188177 286705 543802 -330043 true BANNER SUN HEALTH RESEARCH IN 10515 W SANTA FE DRIVE SUN CITY AR 85351 450233470 242000 0 ALZHEIMERS RESEARCH BOSTON U SCHOOL OF MEDICINE 72 E CONCORD ST BOSTON MA 02118 042103547 501 (C) (3) 266509 0 ALZHEIMERS RESEARCH BRIGHAM & WOMENS HOSP 75 FRANCIS STREET BOSTON MA 02114 042312909 501 (C) (3) 235000 0 ALZHEIMERS RESEARCH CLEVELAND CLINIC FOR BRAIN HE 888 WEST BONNEVILLE AVE LAS VEGAS NV 89106 340714585 501 (C) (3) 1000000 0 ALZHEIMERS RESEARCH COLUMBIA UNIVERSITY MEDICAL C 2700 BROADWAY NEW YORK NY 10025 135598093 501 (C) (3) 150000 0 ALZHEIMERS RESEARCH DUKE CENTER DRUG DISCOVERY 4321 MEDICAL PARK DRIVE DURHAM NC 27704 560532129 501 (C) (3) 149603 0 ALZHEIMERS RESEARCH EMORY UNIVERSITY 1784 DECATUR RD SUITE 510 ATLANTA GA 30322 560566256 501 (C) (3) 401000 0 ALZHEIMERS RESEARCH GEORGETOWN UNIVERSITY 3970 RESERVOIR RD WASHINGTON DC 20007 530196603 501 (C) (3) 140000 0 ALZHEIMERS RESEARCH HOWARD UNIV COLLEGE PHARMACY 2300 4TH ST NW WASHINGTON DC 20059 530204707 501 (C) (3) 110000 0 ALZHEIMERS RESEARCH JOHN HOPKINS SCH OF MEDICINE 1820 LANCASTER STREET BALTIMORE MD 21231 520595110 501 (C) (3) 150168 0 ALZHEIMERS RESEARCH MASS GENERAL HOSPITALHARVARD BLDG 149/13TH ST 6TH FLOOR CHARLESTOWN MA 02129 042697983 501 (C) (3) 275000 0 ALZHEIMERS RESEARCH MAYO CLINIC 200 1ST ST WEST ROCHESTER MN 55905 416011702 501 (C) (3) 146960 0 ALZHEIMERS RESEARCH MEDICAL UNIV SOUTH CAROLINA 171 ASHLEY AVENUE SUITE 403 CHARLESTOWN SC 29425 576000722 501 (C) (3) 230961 0 ALZHEIMERS RESEARCH NATIONAL BIOMEDICAL RESEARCH 411 WAVERLY OAKS RD WALTHAM MA 02452 131926374 501 (C) (3) 100000 0 ALZHEIMERS RESEARCH NYU SCHOOL OF MEDICINE 550 1ST AVENUE NEW YORK NY 10016 135562309 501 (C) (3) 200184 0 ALZHEIMERS RESEARCH OHIO STATE CTR FOR MOLECULAR 1060 CARMACK ROAD COLUMBUS OH 43210 316401599 501 (C) (3) 378336 0 ALZHEIMERS RESEARCH PHARMATROPHIX 2198 STERLING AVENUE MENLO PARK CA 94025 141973571 250000 0 ALZHEIMERS RESEARCH PROVECTRA THERAPEUTICS INC 9025 BALBOA AVE SAN DIEGO CA 92123 416007513 164750 0 ALZHEIMERS RESEARCH R FRANKLIN UNIV MEDICINE 3333 GREEN BAY ROAD NORTH CHICAGO IL 60064 362181973 501 (C) (3) 169152 0 ALZHEIMERS RESEARCH RODIN THERAPEUTICS 25 FIRST ST CAMBRIDGE MA 02141 462300388 182500 0 ALZHEIMERS RESEARCH TUFTS UNIVERSITY 419 BOSTON AVENUE MEDFORD MA 02156 043400617 501 (C) (3) 25000 0 ALZHEIMERS RESEARCH UNIVERSITY OF MINNESOTA 2001 6TH STREET SE MINNEPOLIS MN 55455 416007513 501 (C) (3) 200000 0 ALZHEIMERS RESEARCH US AGAINST ALZHEIMERS 1101 K ST NORTHWEST WASHINGTON DC 20005 450672514 501 (C) (3) 35000 0 ALZHEIMERS RESEARCH VANDERBILT NEUROSCIENCE DRUG 1211 MEDICAL CENTER DRIVE NASHVILLE TN 37232 620476822 501 (C) (3) 150000 0 ALZHEIMERS RESEARCH VIRGINIA COMMONWEALTH 1200 EAST MARSHALL ST RICHMOND VA 23284 596001758 501 (C0 (3) 200000 0 ALZHEIMERS RESEARCH WEILL CORNELL MEDICAL COLLEGE 525 EAST 168TH STREET NEW YORK NY 10021 131623978 501 (C) (3) 500000 0 ALZHEIMERS RESEARCH YUMA THERAPEUTICS 77 POND AVENUE BROOKLINE MA 02445 900506989 174967 0 ALZHEIMERS RESEARCH 21 6 Grantmaker's Description of How Grants are Used GRANT RECIPIENTS ARE SELECTED THROUGH A RIGOROUS PEER-REVIEW PROCESS AS WELL AS AN INTERNAL REVIEW AND BOARD APPROVAL PROCESS. GRANTS FOR ALL INSTITUTIONS ARE CLOSELY MONITORED. GRANTEES MUST SUBMIT MID-YEAR AND END-OF-YEAR PROGRESS AND FINANCIAL REPORTS. SUBSEQUENT PAYMENTS TO GRANT RECIPIENTS ARE CONTINGENT UPON THE RECEIPT AND SATISFACTORY REVIEW OF THESE REPORTS. PROGRESS OF GRANT RECIPIENTS IS COMMUNICATED TO THE BOARD OF GOVENORS PERIODICALLY. SOME OF THE GRANTS LISTED IN PART II OF THIS SCHEDULE I ARE GRANTS WITH A "PARTICIPATING INTEREST," WHICH ENTITLE THE FOUNDATION TO RECEIVE, IN THE EVENT THAT THE FUNDED PROJECT IS LICENSED OR OTHERWISE COMMERCIALIZED, A PERCENTAGE OF THE LICENSING OR OTHER REVENUE THAT THE GRANTEE ORGANIZATION RECEIVES OR EQUITY IN THE RESULTING BUSINESS ENTITY. true false false false false false false false false false HOWARD FILLIT MD EXEC DIR/GOV 429533 108667 150337 688537 217334 NANCY LYNN UNTIL 813 EX. DIR/COO/GOV 285983 100094 386077 NANCY SANFORD PHILANTHROPY 174337 61018 235355 9 80567 MARKET VALUE false false false Client Note 1 Client Note 1 - CONTINUATION SHEET FOR SCHEUDLE I (FORM 990)A GRANT T0 LESANNE LIFE SCIENCE, 1 CHENEY ST., IVORYTON, CT. 06442 WAS APPROVED IN THE AMOUNT OF $260,000 IN 2007. IN 2008, INFORMATION REQUIRED WAS NOT PROVIDED BY lESANNE LIFE SCIENCE. ACCORDINGLY, ALZHEIMER DRUG DISCOVERY FOUNDATION CANCELLED THIS GRANT IN 2008 WHICH IS REFLECTED AS A REDUCTION OF GRANT EXPENSE. Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et THE FOLLOWING FAMILY AND/OR BUSINESS RELATIONSHIPS EXIST AMONG GOVERNORS AND OFFICERS OF THE FOUNDATION: (i) LEONARD A.LAUDER AND RONALD S.LAUDER: FAMILY AND BUSINESS RELATIONSHIP; (ii) LEONARD A.LAUDER, KEVIN DIETERICH, JOAN KRUPSKAS AND LISA SOMAR: BUSINESS RELATIONSHIP;(iii) DR.HOWARD FILLIT, NANCY SANFORD AND NANCY LYNN: BUSINESS RELATIONSHIP;(iv) LEONARD A.LAUDER, RONALD S.LAUDER AND DR. HOWARD FILLIT: BUSINESS RELATIONSHIP;(v) LEONARD A.LAUDER, RONALD S.LAUDER, NANCY SANFORD,AND NANCY LYNN: BUSINESS RELATIONSHIP;(vi) ALICE SHURE AND BONNIE PFEIFER EVANS: FAMILY RELATIONSHIP;(vii) MELVIN R.GOODES and NANCY GOODES: Family Relationship;(viii) LEONARD A. LAUDER AND LADY LYNN DE ROTHCHILD: BUSINESS RELATIONSHIP. Form 990, Part VI, Line 6: Explanation of Classes of Members or Shareholder THE FOUNDATION'S MEMBERS ARE THE SAME INDIVIDUALS WHO SERVE FROM TIME TO TIME AS THE FOUNDATION'S GOVERNORS. Form 990, Part VI, Line 7a: How Members or Shareholders Elect Governing Body THE FOUNDATION HAS MEMBERS WHO HAVE THE RIGHT TO ELECT AND REMOVE (WITH CAUSE) THE FOUNDATION'S GOVERNORS AND, UNDER APPLICABLE STATE LAWS, APPROVE FUNDAMENTAL CORPORATE CHANGES, SUCH AS A MERGER OR DISSOLUTION OF THE FOUNDATION. Form 990, Part VI, Line 11b: Form 990 Review Process A draft of the completed Form 990 is reviewed by the Foundation's Executive Director and by outside consultants, including legal counsel. The approved final Form 990 is signed by either the Foundation's Executive Director or Treasurer and then a copy is provided to the Board of Governors and the Foundation's officers prior to its filing with the Internal Revenue Service. Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts AT LEAST ANNUALLY, THE CONFLICT OF INTEREST DISCLOURE STATEMENTS ARE CIRCULATED TO THE BOARD OF GOVERNORS AND OFFICERS FOR REVIEW AND COMPLETION. THE COMPLETED STATEMENTS ARE THEN REVIEWED UNDER THE SUPERVISION OF A FOUNDATION OFFICER. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available ONLY UPON REQUEST INSTITUTE FOR THE STUDY OF AGING INC 57 WEST 57TH STREET NEW YORK NY 10019 201082179 GRANTS TO SUPPORT RESEARCH FOR COGNITIVE NY 501(C)(3) PRIVATE FOUNDATION N/A false INSTITUTE FOR THE STUDY OF AGING 57 WEST 57TH STREET NEW YORK NY 10019 201082179 DECLINE & ALZHEIMER IN KIND CONTRIBUTION NY 501 (C) (3) PRIVATE FOUNDATION N/A false INSTITUTE FOR THE STUDY OF AGING 57 WEST 57TH STREET NEW YORK NY 10019 201082179 FOR SALARIES, BENEFITS AND OTHER EXPENSE NY 501 (C) (3) PRIVATE FOUNDATION N/A false ALZHEIMERS DRUG DISCOVERY FOUNDATION OF CANADA 100 KING ST., TORONTO ONTARIO CA M5X 1G5 DRUGS TO PREVENT, CURE, ALZHEIMER'S CA N/A CANADIAN NON PROFIT N/A false false false false false false false false false false false false false true true true true false false false INSTITUTE FOR THE STUDY OF AGING INC m 42512 ACTUAL EXPENSE INSTITUTE FOR THE STUDY OF AGING INC n 760943 ACTUAL EXPENSE INSTITUTE FOR THE STUDY OF AGING INC o 2241816 ACTUAL EXPENSE INSTITUTE FOR THE STUDY OF AGING INC p 63718 CASH TRANSFER